A scientist at the Gladstone Institutes has discovered a novel way to convert human skin cells into brain cells, advancing medicine and human health by offering new hope for regenerative medicine and personalized drug discovery and development. In a paper being published online today in the scientific journal Cell Stem Cell, Sheng Ding, PhD, reveals efficient and robust1 methods for transforming adult skin cells into neurons that are capable of transmitting brain signals, marking one of the first documented experiments for transforming an adult human's skin cells into functioning brain cells.
"This work could have important ramifications2（分枝，分叉） for patients and families who suffer at the hands of neurodegenerative diseases such Alzheimer's, Parkinson's and Huntington's disease," said Lennart Mucke, MD, who directs neurological research at Gladstone. "Dr. Ding's latest research offers new hope for the process of developing medications for these diseases, as well as for the possibility of cell-replacement therapy to reduce the trauma3 of millions of people affected4 by these devastating5 and irreversible conditions."
The work was done in collaboration6 with Stuart Lipton, M.D., Ph.D., who directs the Del E. Webb Neuroscience, Aging and Stem Cell Research Center at Sanford-Burnham Medical Research Institute. Dr. Ding, one of the world's leading chemical biologists in stem-cell science, earlier this year joined Gladstone and the faculty7 at the University of California San Francisco (UCSF), as a professor of pharmaceutical8（制药的） chemistry. Gladstone, which is affiliated9 with UCSF, is a leading and independent biomedical-research organization that is using stem-cell research to advance its work in its three major areas of focus: cardiovascular（心血管的） disease, neurodegenerative disease and viral infections.
Dr. Ding's work builds on the cell-reprogramming work of another Gladstone scientist, Senior Investigator10 Shinya Yamanaka, MD, PhD. Dr. Yamanaka's 2006 discovery of a way to turn adult skin cells into cells that act like embryonic11 stem cells has radically12 advanced the fields of cell biology and stem-cell research.
Embryonic stem cells—"pluripotent" cells that can develop into any type of cell in the human body—hold tremendous promise for regenerative medicine, in which damaged organs and tissues can be replaced or repaired. Many in the science community consider the use of stem cells to be key to the future treatment and eradication13（消灭，根除） of a number of diseases, including heart disease and diabetes14. But the use of embryonic stem cells is controversial—which is one reason why Dr. Yamanaka's discovery of an alternate way to obtain human stem cells, without the use of embryos15, is so important.
Dr. Ding's work extends Dr. Yamanaka's by offering still another method for avoiding the use of embryonic stem cells and creating an entirely16 new platform for fundamental studies of human disease. Rather than using models made in yeast17, flies or mice for disease research, all cell-reprogramming technology allows human brain, heart and other cells to be created from the skin cells of patients with a specific disease. The new cells created from the skin cells contain a complete set of the genes18 that resulted in that disease—representing the potential of a far-superior human model for studying illnesses, drugs and other treatments. In the future, such reprogrammed skin cells could be used to test both drug safety and efficacy（功效） for an individual patient with, for example, Alzheimer's disease.
收听单词发音 
